The Lessons Learned When a Company Overstated Products’ THC Potency
by Chane Leigh
The legal cannabis market has been on the rise for quite some time. Statistics published in Stellar Market Research’s new report indicate that the industry is set to continue skyrocketing. The market was valued at USD $28.26 billion in 2021, and total revenue is predicted to surge at a compound annual growth rate (CAGR) of 32.04% between 2022 and 2027.
According to industry analysts, the cannabis market will soar to a valuation of $149.8 billion by the year 2027. The new report examines market growth drivers and segments. Several notable participants provided data for the report, highlighting a handful of dominant regions, including APAC, Europe, MEA, North America, and South America.
Key data analysis featured in the report extends over a three-year historical period from 2017-2020. In addition to the unique cannabis markets, challenges, growth drivers, limitations, and opportunities featured in Stellar Market Research’s detailed analysis, the report also features investor recommendations.
Researchers from Stellar Market Research have outlined several key factors stimulating industry success, including increasing disposable incomes. According to the report, the increasingly aging population and illness amplify the demand for medicinal cannabis. Older adults face a higher risk of developing chronic diseases, such as arthritis, cancer, epilepsy, and migraines. As a result, more physician visits are necessary.
The researchers also spotlighted rising demand in the agriculture sector for legal cannabis. Pesticides can be created using recreational cannabis, thus offering agricultural workers the opportunity to utilize a less harmful option than conventional pesticides.
Furthermore, the report emphasizes that cannabis offers a safer alternative to traditional treatment options and produces fewer adverse side effects. Additionally, cannabis-based medicines allow patients to minimize their opioid dosage and frequency while still benefiting from pain relief.
As a plant that is shrouded in misconception, many governments are outlawing the use of cannabis. Even though cannabis is permitted in specific regions of Africa, Europe, North America, and South America, it is still forbidden by law in the majority of Middle Eastern and Asian countries, including Japan, India, and Korea. Due to these strict regulations, consumption, possession, purchase, and sale are deemed criminal acts. Consequently, cannabis market growth is somewhat restricted.
The potentially adverse side effects of specific cannabis strains—particularly those rich in the psychoactive compound delta-9 tetrahydrocannabinol (THC)—hinder market growth. The Stellar Market Research team also noted the addictive nature of cannabis as one of the restraints to the cannabis market. While cannabis is believed to be non-addictive, dependence on the plant has been explicitly documented.
Cannabis legalization is unfolding across the Asia Pacific region—something that has been largely stimulated by the rise of legal cannabis across most nations in Europe, North America, and South America. China, which already boasts a significant market for industrial hemp, is expected to emerge as a serious contender for industrial cannabis in the foreseeable future.
A focal point of the report was that many key players in the cannabis businesses are patiently waiting for legislative advancement in the Asia Pacific area. If and when this happens, numerous countries across the region stand to reap the rewards of large-capacity, low-cost production. Researchers believe that this will open up immense opportunities for legal cannabis.
To achieve a clearer understanding of growth drivers in the legal cannabis industry, researchers segmented the market as follows:
Some of the key takeaways of this report were as follows:
Click here to read the full cannabis market report from Stellar Market Research.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
The war on drugs facilitated by the federal government has been an utter failure. Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. While this classification will remain…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021 review published in Current Neuropharmacology, targeting the endocannabinoid system with CBD may offer those affected by borderline personality disorder newfound relief and understanding about managing their condition. What Is Borderline Personality Disorder? Borderline…
Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Despite the law’s passing, CBD…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through…
A national survey showed that cannabis is America’s “illicit drug” of choice, medical professionals released the first ever cannabis consumer-specific anesthesia guidelines,…